Why New Market Launches Stall and What's Actually Causing the Delay

She saw it coming three months out.

A senior marketing director at a major CPG company with brands across Latin America described a pattern she lived through repeatedly. Her team would launch a product in North America in January. They'd know right then that they wanted to bring it into Mexico, Chile, and Brazil. They'd start the paperwork immediately.

But the paperwork would take six to eight months.

By the time local permits cleared and marketing assets were approved for each market, the product had been on US shelves for half a year. The national launch moment had passed, the media budget had been spent and the consumer excitement fizzled.

"By the time you launch here, so much time has passed that the novelty of the item is no longer as cool as it could be. Plus you don't take advantage of the national communications that are happening around a new product when the gap is so wide."

She called it "such a hurdle." She was being polite.

What she was describing is one of the most consistent, most expensive, and least-discussed problems in global CPG. Call it the Novelty Gap: the distance between when a product is ready and when it's approved to ship in a new market is measured not in weeks, but in competitive opportunity lost.

This Is Not a Supply Chain Problem

When a launch slips, most organizations blame the obvious suspects: Manufacturing timelines, retailer negotiations, distribution logistics, or procurement delays.

Those are real friction points but they're not what's actually stalling multi-market launches in 2026. As GlobalVision's 2026 CPG label compliance analysis found, one of the biggest failure modes is product data living in "scattered spreadsheets, emails, and drive folders" where teams update a formula but forget to update the allergen statement on the artwork. The real bottleneck isn't the factory, it's the approval chain.

In March 2026, Puntt AI surveyed 107 enterprise compliance and marketing executives across regulated consumer goods companies. The finding was stark: 89% of regulated companies say review capacity — not manufacturing or technical limits — is what slows their speed to market.

Minor packaging or label changes add 4–8 weeks to launch timelines from review backlogs alone. Full approval cycles stretch 6–18 months. And 73% of companies are dedicating entire offshore teams to manual verification tasks that automated systems could handle.

The Sequential Workflow Problem

The reason approval cycles run so long is structural, not cultural. Review work is sequential by design. Creative waits for brand, then Brand waits for Regulatory, then Regulatory waits for R&D, and so on. Each function processes in full before passing to the next with no way to differentiate what genuinely needs expert judgment from what's identical to something already approved.

A SVP at a global consumer health company put it directly: "When a small change in an ingredient, a regulatory requirement, or a claim triggers the need to change artwork, approval templates need to be re-opened. For most organizations, these reopened templates need to be fully verified and approved again by regulatory and legal functions, even if most of the elements remain unchanged. Organizations are currently paying teams to repeat identical checks that could be easily automated."

94% of legal and regulatory teams require full manual re-verification of elements that haven't changed. Every time a single element is updated like an address, a minor ingredient swap, a market-specific regulatory requirement, the entire chain restarts.

When one element changes, the clock resets to zero.

The Multi-Market Multiplier

The problem compounds the moment you add markets.

Every new geography brings its own regulatory body, labelling requirements, claims restrictions, and approval timelines. What cleared in the US may need reformulation for the EU. What works in Germany may be non-compliant in France. And what passes in Mexico may be blocked in Chile. You get the idea.

78% of companies selling in multiple markets report multi-day regulatory review cycles for each formula change across 40+ jurisdictions. And 81% maintain manually updated compliance databases that go out of date within weeks of being refreshed.

In our survey, one global supplement company operating in approximately 40 markets described a compliance process that runs entirely by hand: every month, a team member sends emails to regulatory consultants in each market, asking about ingredient approvals. Responses come back individually. The team manually cross-references every ingredient against every market before anything ships. It works, but just barely. And every new market entry is gated by the slowest inbox in that month's queue.

This isn't an isolated case. It's the industry standard.

Meanwhile, AI is producing more marketing content than ever. The bottleneck used to be creation. AI has fixed that but now the bottleneck is the approval process, which is still largely manual.

What the Novelty Gap Actually Costs

The cost is rarely captured in a single line item, which is why it keeps getting tolerated.

It shows up as missed seasonal windows such as a product ready in October doesn't get approved until February. The holiday moment is gone. The long lead time is now just accepted as the cost of expanding.

It shows up as wasted coordination. The national campaign runs in the lead market with full media support. Six months later, the same product trickles into secondary markets with no campaign momentum left, no launch energy, no national comms to ride.

It shows up as 70% rework rates. A marketing and comms director at a global food and beverage company described it precisely: "Most of our innovation-to-launch processes, we have roughly 70% rework. The way of asking is not necessarily standardized, so it's not necessarily clear to the designer where the mistake happened."

And it shows up as competitive exposure. While your team waits for sign-off on revision three of a label, a faster competitor ships, or  the shelf space is taken after the distributor/retailer relationship is affected.

Product innovation cycles that take up to 18 months arrive too late to capture bifurcating consumer demand. The review cycle isn't a back-office inefficiency. It is eating the market window.

What It Looks Like When This Is Solved

One global food and beverage brand now runs every marketing asset and piece of artwork through Puntt before it ships. What used to sit in manual review queues — 10,000 assets a year — now runs through AI review agents that can process 1,000 assets a day. What took a year can now be done in ten days.

A leading European marketing team uses Puntt to review shopper assets against brand and regulatory requirements across multiple markets. The system learns from past human decisions — not just written guidelines, which are rarely followed perfectly — and applies that institutional knowledge consistently, at scale.

The change isn't that legal and regulatory teams are replaced, they’re empowered. The change is that everything that doesn't require expert judgment gets handled before it reaches them. They review the exceptions, not the queue. Launches that used to take weeks take days. And when a new market opens, the regulatory rules for that market are already in the system.

The Window Is the Strategy

The marketing director in Latin America wasn't wrong about the market potential. She wasn't wrong about the timing, the consumer appetite, or the product. She was right about all of it.

The paperwork took eight months. The window of opportunity was three months.

That gap — between when you're ready and when you're approved — isn't a compliance problem. It's a competitive strategy problem. And for most global CPG companies right now, it is entirely unmanaged.

Click here to book a demo.

Frequently Asked Questions

Why do new market launches take so long?

New market launches stall primarily because of sequential approval workflows, not manufacturing or logistics. Marketing assets, packaging, and claims have to clear brand, legal, regulatory, and R&D sign-off one function at a time. In multi-market CPG companies, that chain stretches 6–18 months. According to a Puntt AI survey of 107 enterprise executives (March 2026), 89% of regulated companies say review capacity — not technical or manufacturing limits — is what slows their speed to market.

What is the Novelty Gap in CPG product launches?

The Novelty Gap is the time between when a product is ready to ship and when it's actually approved to launch in a new market. For global CPG brands expanding into international markets, this gap typically runs six to eight months — long enough for the original launch momentum, media spend, and consumer excitement in the lead market to have dissipated entirely by the time the new market goes live.

Why does changing one thing on packaging restart the entire approval process?

Most regulated enterprises run sequential approval workflows where each function — creative, brand, regulatory, legal, R&D — must fully verify an asset before passing it to the next. There is no mechanism to distinguish what changed and needs fresh review from what is identical to a previously approved version. A single update, even an address change, reopens the entire template. 94% of legal and regulatory teams require full manual re-verification of elements that haven't changed.

How do multi-market CPG companies manage regulatory compliance across 40+ countries?

Most do it manually. Teams maintain spreadsheets or databases of market-specific regulatory requirements, updated periodically by hand. Ingredient approvals are often verified by emailing local regulatory consultants market by market. 81% of multi-market companies maintain manually updated compliance databases that go out of date within weeks. This approach doesn't scale — and it means every new market entry is gated by the slowest response in that month's queue.

What's the real cost of slow marketing approval cycles?

The costs are rarely captured in a single line item: missed seasonal launch windows, wasted media spend when secondary markets launch too late to ride campaign momentum, 70% rework rates from unstructured feedback, and competitive exposure when faster rivals take shelf space during extended review periods. In regulated industries, approval capacity — not manufacturing — is now the primary constraint on speed to market.

How can AI reduce marketing approval cycle time?

AI review agents can process routine compliance checks — brand alignment, regulatory claim validation, market-specific labelling requirements — automatically and in parallel, rather than sequentially. In one deployment, a global food and beverage brand processes 10,000 assets a year through Puntt AI, with the system handling 1,000 assets a day. The key is that AI handles the high-volume routine checks so legal and regulatory teams can focus their judgment on the decisions that genuinely require it.

What's the difference between a productivity tool and a governed AI review system?

A productivity tool speeds up output. A governed AI review system speeds up output within a defined, auditable boundary — so every decision is logged, every compliance-relevant judgment is either resolved automatically or escalated to the right human, and when something goes wrong, there's a clear record of what happened and why. In regulated marketing, that distinction matters: a productivity tool can't answer a regulator's questions. A governed system can.